Concepedia

Onintza Sagredo

OS

20

Publications

2.1K

Citations

17

H-Index

2002

Active since

Affiliations

Universidad Complutense de Madrid(Current)

Biomedical Research Networking Center on Neurodegenerative Diseases

Instituto Ramón y Cajal de Investigación Sanitaria

Hospital Universitario Fundación Alcorcón

Centro de Investigación Biomédica en Red

Onintza Sagredo is an author at Universidad Complutense de Madrid specializing in neuroscience, medicine, and social sciences.

ORCID

Top concepts

Publications per year

2002–2023

20

Publications

20

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Javier Palazuelos, Tania Aguado, M. Ruth Pazos et al. · Brain · 2009 · 375 citations · Full text

, , +21

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease

Cristina Blázquez, Anna Chiarlone, Onintza Sagredo et al. · Brain · 2010 · 195 citations · Full text

Cannabinoid CB<sub>2</sub>receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease

Onintza Sagredo, Sara González, Ilia Aroyo et al. · Glia · 2008 · 194 citations · Full text

A restricted population of CB <sub>1</sub> cannabinoid receptors with neuroprotective activity

Anna Chiarlone, Luigi Bellocchio, Cristina Blázquez et al. · Proceedings of the National Academy of Sciences · 2014 · 158 citations · Full text

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

José Luis López-Sendón, Juan García Caldentey, Patricia Trigo Cubillo et al. · Journal of Neurology · 2016 · 151 citations

, , +10

Rows per page

1–5 of 20